Biomatter is a synthetic biology company creating new-to-world enzymes for medicine, agriculture, chemical biomanufacturing, life scienceapplications. By partnering with global companies (incl. Thermo Fisher Scientific, BASF, Neogen) across different industries, Biomatter launches new bio-based products and technologies enabled by their unique enzymes. This funding round marks a significant milestone for Biomatter, positioning the company well for completing the next major milestones and future growth.